PTPN6 and chronic obstructive pulmonary disease: In patients, Shp1 mutations are associated with neutrophilic dermatitis and chronic obstructive pulmonary disease (COPD), the latter suggesting a role for Shp1 dysregulation in human lung diseases (24–26).